THERE IS BOTH A SHORT AND LONG OPPORTUNITY IN NASDAQ:TREE , THE STOCK IS SETTING UP FOR A BREAKOUT BUT THERE IS SOME BEARISH DIVERGENCE ON THE CHART, A BREAK OF $400 BULLISH, ON THE OTHER HAND A FAILED BREAKOUT IS A FANTASTIC OPPORTUNITY TO SHORT. SHORT INTEREST 24% COMPANY PROFILE LendingTree, Inc. engages in the operation of online loan marketplace for...
===================== ANFI (Amira Nature Foods Ltd.) Float: 25.82M Alert Price: $1.05 Target Price: $6.00 Chart Analysis Investor Presentation Investor Webcast Website | Recent News ======================== Members, Our biggest NYSE-listed winner of 2019 looks ready to breakout big once again! It's time to add ANFI (Amira Nature Foods Ltd.)...
****SCANNERS HAVE ALERTED US TO THE STOCK OF NYSE:BB WITH A POSSIBLE REVERSAL TRADE IN THE COMING DAYS. WISE TO WAIT FOR CONFIRMATION FROM STRONG VOLUME, MACD CROSS AND BULLISH ENGULFING CANDLE, RSI IS ALSO RECOVERING****** SET ALERTS FOR BREAK OF $8.50 FOR MORE BULLISH ENTRY.
********HUGE POTENTIAL PROFITS ON IMPENDING BREAKOUT AFTER FORMING CAP AND HANDLE , WE AWAIT A UPTAKE IN VOLUME AND A BREAK ABOVE $59 TO CONFIRM SETUP, INDICATORS ARE ALL BULLISH, LOOKS LIKE A GEM***** AVERAGE ANALYSTS PRICE TARGET $67 AVERAGE ANALYST RECOMMENDATION BUY COMPANY PROFILE Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages...
*****Purely based on technical setup in NASDAQ:CPRT looks like a very good possibility of a major breakout in the coming days set alert for $72.50. ********* COMPANY PROFILE Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. It provides vehicle sellers with a full range of services to process and sell vehicles primarily...
********HOT STOCK FOR THE DAYS TO COME ON THE BACK OF NEW DEBT REFINANCING AGREEMENT ANNOUNCED MONDAY. RALLY STALLED WITH THE MARKET BUT SHOULD SEE GREATER GAINS IN THE DAYS TO COME. BREAK ABOVE THE 50MA AND MACD CROSS NICE SIGNALS FOR A LONG. COMPANY PROFILE Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of...
NASDAQ:ATXI TRADED ON HIGH VOLUME AND A INITIAL 30% PRICE SPIKE ON MONDAY BUT SOLD OFF AS THE MARKET CONDITIONS DETERIORATED THROUGHOUT THE DAY. KEEP ON STRONG WATCH AS A MUCH GREATER MOVE IS EXPECTED ON SUCH STRONG RESULTS. COMPANY COMMENTS “The strong safety and efficacy results from this second Phase 3 trial are consistent with those from the first Phase 3...
The company today announced that they had received approval to move onto clinical trials on humans with their CD19 t-haNK therapy. TODAY'S STATEMENT “Based on extensive and encouraging preclinical results, we have enhanced our ability to modularly combine this proprietary off-the-shelf t-haNK-based therapy with a wide range of monoclonal antibodies using this...
FROM A TECHNICAL PERSPECTIVE THE CHART OF NYSE:CHK IS NOT PRETTY BUT THE PRICE IS REACHING A CRITICAL SUPPORT LEVEL, ON WHICH A REVERSAL TRADE COULD BE VERY PROFITABLE ONE. HOPEFULLY COMMODITIES CAN FIND A BOTTOM TO HELP SUPPORT THIS HORRIFIC SECTOR. SHORT INTEREST 17.47% AVERAGE ANALYSTS PRICE TARGET $3.07 AVERAGE ANALYSTS RECOMMENDATION UNDERWEIGHT P/E...
****THERE IS NO LIGHT AT THE END OF THE TUNNEL FOR NYSE:GME EXPECTATIONS FOR TOMORROWS EARNINGS ARE ZERO. THE ONLY HOPE FOR GME IN THE FUTURE IS A TAKEOVER, BUT IT IS HARD TO SEE WHY ANYONE WOULD WANT IT AT$7.50 WHEN THEY COULD GET IT AT $2.50. SHORT INTEREST 39% AVERAGE ANALYSTS PRICE TARGET $9.90 AVERAGE ANALYSTS RECOMMENDATION HOLD COMPANY...
*****ON THE WATCHLIST FOR NEXT WEEK AS STOCK HAS BEEN ACTING QUITE BULLISH IN RECENT DAYS***** CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins,...
*******June is setting up to a very big month for NASDAQ:NVUS and some very profitable trades may on the offering,. Keep track of the notable dates listed below for results and presentations. Accumulation has already began in anticipation of positive news. ********** AVERAGE ANALYSTS PRICE TARGET $8.75 AVERAGE ANALYSTS RECOMMENDATION BUY UPCOMING MARKET...
*******KEEP ON THE WATCHLIST FOR NEXT WEEK, MUCH GREATER MOVES EXPECTED ON MORE NEWS, PURELY SPECULATIVE ***** COMPANY PROFILE Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and...
*****HOT STOCK FRIDAY, KEEP ON THE RADAR FOR MAJOR CONTINUATION IN THE DAYS AND WEEKS TO COME.******** AVERAGE TARGET PRICE $25.67 AVERAGE RECOMMENDATION BUY COMPANY DETAILS Genocea is a biopharmaceutical company developing personalized cancer immunotherapies. Our unique ATLAS™ technology platform allows us to identify immunotherapy targets based on each...
SPECULATION AND RUMORS HAVE PUT THIS STOCK ON THE WATCHLIST FOR THE WEEKS TO COME, HAD A GOOD DAY ON FRIDAY WITH A 7%SPIKE ON GOOD VOLUME, WHICH MAY HAVE BEEN HAMPERED BY THE MARKET SENTIMENT. STOCK HAS SUFFERED RECENTLY FROM A SPLIT AND OFFERING SO WE AWAIT A POSITIVE CATALYST. COMPANY PROFILE Auris Medical Holding Ltd. engages in the development of novel...
******THE STOCK OF NASDAQ:WPRT HAS HAD SOME FANTASTIC PRICE ACTION FOLLOWING A FANTASTIC EARNINGS REPORT WHICH HAS CAPTURED THE ATTENTION OF INVESTORS. LOOK OUT FOR CONTINUATION OF THE TREND TOWARDS $3.60******** RECENT EARNINGS HIGHLIGHTS "Our Q1 2019 results are another validation of our strategy and reflect improved performance across all of our...
***$$$$$$$$$$$$$$$$$$$$$$$ASSOCIATION WITH GOOGLE FOR SUCH A SMALL CAP JUST MEANS $$$$$$$$$$$$$$$$$$$$$* Earnings report Highlights Revenues for the three months ended March 31, 2019 decreased by $0.38 million, or 3%, as compared to the three months ended March 31, 2018, mainly because we did not pursue certain low margin, professional services business during...
The stock of NASDAQ:HYGS was flagged yesterday for its volume and price spike, resulting in a new 3 year high. We are now on the lookout for continuation and a full scale breakout move. COMPANY PROFILE Hydrogenics Corp. designs, develops and manufactures hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange...